These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1167447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH, Smee ML, Woolston ME.
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract] [Full Text] [Related]

  • 3. A comparative study of d- and l-amphetamine on the open field performance of rats.
    Dandiya PC, Kulkarni SK.
    Psychopharmacologia; 1974; 39(1):67-70. PubMed ID: 4472934
    [No Abstract] [Full Text] [Related]

  • 4. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy.
    Segal DS, Mandell AJ.
    Pharmacol Biochem Behav; 1974; 2(2):249-55. PubMed ID: 4857295
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of two dopamine receptor blockers on a serotonin-mediated behavioral syndrome in rats.
    Jacobs BL.
    Eur J Pharmacol; 1974 Aug; 27(3):363-6. PubMed ID: 4472582
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L, Anisman H.
    Psychopharmacology (Berl); 1979 Jun 28; 64(1):45-54. PubMed ID: 113831
    [Abstract] [Full Text] [Related]

  • 10. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
    Segal DS, Weinberger SB, Cahill J, McCunney SJ.
    Science; 1980 Feb 15; 207(4433):905-7. PubMed ID: 7188815
    [Abstract] [Full Text] [Related]

  • 11. Sex differences in stereotyped behavior in the rat.
    Beatty WW, Holzer GA.
    Pharmacol Biochem Behav; 1978 Dec 15; 9(6):777-83. PubMed ID: 570708
    [No Abstract] [Full Text] [Related]

  • 12. The use of d-amphetamine pellet implantation as a model for d-amphetamine tolerance in the mouse.
    Hitzemann RJ, Loh HH, Craves FB, Domino EF.
    Psychopharmacologia; 1973 Jun 19; 30(3):227-40. PubMed ID: 4736782
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tolerance to the behavioral and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol.
    Puri SK, Lal H.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Jun 19; 282(2):155-70. PubMed ID: 4277740
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mesolimbic involvement with behavioural effects indicating antipsychotic activity.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1974 Jun 19; 27(1):46-58. PubMed ID: 4604756
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency.
    Ljungberg T, Ungerstedt U.
    Psychopharmacology (Berl); 1979 Feb 28; 60(3):303-7. PubMed ID: 108708
    [No Abstract] [Full Text] [Related]

  • 19. Determinants of amphetamine-produced stereotyped behavior in the rat.
    Russell RL, Pihl RO.
    Psychol Rep; 1978 Oct 28; 43(2):575-9. PubMed ID: 569344
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.